The 72-hour cold chain to Lagos: what really breaks between Mumbai and West Africa.

Every cold-chain pharmaceutical shipment into West Africa lives or dies on the gap between validated shipping time and realistic dwell time. The first number is printed on the shipper datasheet. The second is what actually happens in Lagos in July, and those two numbers are the beginning and end of the entire conversation.

The Mumbai–Lagos lane, hour by hour

Here is the honest breakdown of a validated 2–8°C shipment from a Mumbai export warehouse to a Lagos hospital pharmacy, on an Emirates or Ethiopian Airlines routing. Times are median — the long tail is where cold-chain shipments get killed.

• 0h: Pack-out at Mumbai warehouse. Qualified shipper pre-conditioned, gel packs at correct temperature, logger armed, batch documents sealed into the outer envelope.
• +4–8h: Road move to BOM cargo terminal. This is already a live cold-chain event — the logger is running.
• +10–18h: Airline acceptance, screening, build-up onto ULD or dry-ice pallet. Dwell on the BOM tarmac is where the first excursion risk lives, especially in April-to-June heat.
• +20–32h: Transit via DXB or ADD hub. Transfer dwell is the second risk window.
• +40–52h: Arrival at LOS. Clearance and NAFDAC inspection starts.
• +60–84h: Release to importer, onward move to hospital or distributor warehouse.

Total: 60–84 hours, on a shipper rated for 96 hours of thermal holdover. The safety buffer is thin. Every unnecessary hour eats into it.

Where it actually breaks

Three failure points, in order of how often we see them over a rolling year of West-African cold-chain work:

1. Tarmac dwell at BOM before load. Pre-monsoon, the apron temperature is 38–42°C. A shipper that sits on the tarmac for four unscheduled hours has burned its safety buffer before the aircraft has even left India.
2. Transit hub delays at DXB or ADD. A missed connection adds 12–24 hours. Every hour at a transit hub is an hour of thermal holdover spent, and only the second-leg carrier knows where the shipper actually is.
3. NAFDAC inspection queue at LOS. A first-time importer without a pre-lodged permit can sit for 3–5 days in a warehouse that may or may not have reliable power. That is a shipper-killer.

NAFDAC and the inspection queue

Nigeria's National Agency for Food and Drug Administration and Control runs one of the stricter port inspection regimes in West Africa — and it is stricter for good reason. For cold-chain imports specifically, the operational realities to plan around are:

• Pre-registration is non-negotiable. The product must already be registered with NAFDAC before the shipment is booked. Named-patient and emergency exemptions exist, but they require separate paperwork.
• Import permit precedes shipment. The NAFDAC permit is issued against a specific invoice, batch and quantity. Quantity discrepancies trigger a hold.
• Physical inspection on arrival. NAFDAC officers open a sample shipper at the airport warehouse. The shipper must be visibly intact, the logger must be running, and the documents must match the packaging.
• Cold-chain holding. The NAFDAC warehouse at Murtala Muhammed cargo terminal has cold-chain holding — but capacity fluctuates. On a heavy arrival day, shipments can be held in ambient conditions. This is the bit nobody will tell you in a brochure.

The mitigation is boring and effective: clear the permit and the CoPP before the aircraft leaves Mumbai, ship with an importer who has a named NAFDAC relationship, and accept that the fastest way to clear a cold-chain shipment in Lagos is to have done the paperwork two weeks ahead of it.

Accra and Nairobi: similar lane, different sharp edges

Ghana's FDA runs a more permit-focused, less physical-inspection-heavy process than NAFDAC. The lane into Kotoka International is shorter than the Lagos lane, and the cold-chain handling at KIA is, year for year, more reliable. The sharp edge in Accra is not the airport — it is the upcountry delivery to Kumasi or Tamale in the warm season, where a 2–8°C van that sits at a checkpoint for two hours is genuinely at risk.

Kenya's PPB (Pharmacy and Poisons Board) runs a streamlined import pathway through Jomo Kenyatta International. The logistics in Nairobi are closer to GCC standards than to West African ones. The sharp edge there is the onward move to Mombasa, or across the Uganda or Rwanda borders — every border crossing adds documentary and thermal risk.

The three logger readings that decide batch release

At destination, the quality-release decision for a cold-chain batch is made against three logger readings. Everyone involved should know what they are, because they are the difference between release and destruction:

1. Maximum temperature reached. If the maximum exceeded the product's upper excursion limit, how long did it exceed for?
2. Cumulative time outside range. Bounded excursions are manageable. A shipment that spent six hours at 9°C is not the same as one that spent fifteen minutes at 9°C, even if the peak temperature is identical.
3. Thermal inversion events. A shipment that went briefly below the lower limit (below 2°C for a standard refrigerated product) is a separate failure mode — it usually indicates dry-ice contact rather than an upper-limit excursion.

A supplier that ships cold-chain seriously gives you all three readings, every time, before you ask.

Writing an excursion protocol that survives audit

The minimum viable cold-chain excursion protocol is three pages:

• Scope: which SKUs, which routes, which temperature ranges.
• Notification: who is informed, in what order, within what time window, when an excursion is detected.
• Decision framework: the matrix of excursion magnitude × duration × product stability data that determines release, quarantine, or destruction.
• Documentation: logger download, stability-data reference, signed-off decision, and the archived file.
• Insurance reference: which policy covers replacement, who triggers it, and the claim workflow.

If your supplier cannot produce their excursion protocol on request, you are shipping cold-chain on hope. Hope is not a quality system.

FAQ

How long does a Mumbai-to-Lagos pharmaceutical cold-chain shipment take?

60 to 84 hours door-to-door on a validated 2–8°C shipper, using a major carrier via a Gulf or East African hub. The shipper is typically validated for 96 hours, giving a safety buffer of 12–36 hours against realistic dwell variance.

What happens if a temperature excursion occurs in transit?

The excursion is logged on the shipment logger, reviewed against the product's stability data, and a release decision is made by the supplier's quality team under the written excursion protocol. Bounded, short excursions are often releasable. Prolonged or uncontrolled excursions require destruction. The decision is documented and shared with the importer before release.

Does M Care run cold-chain shipments into West and East Africa?

Yes. We have running 2–8°C and −20°C lanes into Nigeria, Ghana, Kenya and South Africa, with validated shippers, logger data on every unit, and a written excursion protocol. Contact the desk with the product, the destination and the volume — we'll quote with the cold-chain cost itemised, not buried.

Can you ship biologicals and vaccines specifically?

Yes, subject to product-by-product dossier and destination-authority approval. Biologicals and vaccines run on the same lanes as standard cold-chain pharma but require additional stability documentation and, for vaccines specifically, destination-country immunisation-programme alignment.